Science & Humans

Based in Ontario, Canada, Global Zebra, Inc. dba Science & Humans specializes in innovative hormone health solutions, providing a range of hormone treatments, including therapies for sexual wellness and weight management. Science & Humans is a provider of hormone health services, established in 2018 in Mississauga, Canada. The company has successfully completed 2 deals, with its most recent funding round occurring on December 31, 2025.

In this Series A round, Science & Humans raised USD 7. 00 mn, led by Pender Ventures, with participation from WELL Ventures. The total amount raised in Series A and venture debt funding is USD 10. 00 mn.

Science & Humans is a leading provider of modern hormone treatments, focused on enhancing hormone health through a range of scientifically-backed solutions. The company offers an array of services, including hormone replacement therapies, weight loss programs, hair loss treatments, and sexual wellness solutions, all designed to address specific medical conditions and lifestyle challenges. These offerings cater to diverse customer bases, including individuals experiencing low testosterone, menopause symptoms, and other hormonal imbalances. The company's products are designed for use primarily in Canada, with a strong emphasis on providing convenient access to healthcare services through a telehealth platform.

Customers benefit from personalized coaching, evidence-based medications, and the convenience of home delivery, thereby enhancing the overall patient experience. The revenue model for Science & Humans is structured around direct-to-consumer transactions, allowing clients to access a variety of hormone health services through subscription-based plans and one-time purchases. Clients typically engage with the company's offerings through an online platform, where they can consult with licensed healthcare professionals and receive customized treatment plans. Each service, such as hormone replacement therapy or weight loss programs, is priced according to specific treatment protocols, ensuring clients receive tailored solutions that meet their individual needs.

The business model hinges on a seamless integration of telehealth consultations and the fulfillment of prescribed treatments through Canada’s largest online pharmacy, thereby streamlining the purchasing process for consumers. In December 2025, Science & Humans raised USD 7. 00 mn in Series A funding, which will be utilized to expand its operations across Canada and grow its B2B business that partners with companies to provide hormone care for employees. The company is focused on developing new products to enhance its service offerings, although specific release dates have not been disclosed.

This strategic expansion is aimed at increasing market presence and accessibility to its services.